Delivery Order SPE2DB22D3401-SPE2DB24FT3ES

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,741.62 for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a firm fixed price pricing type and an ultimate completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order valued at $1,161.08 for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, placed by the Defense Logistics Agency (DLA). The contract has a period of performance through November 7, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract worth $2,902.70 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order valued at $12,653.00 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price arrangement. Amerisourcebergen has been awarded numerous federal contracts, including a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $8,276.19, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order without a set-aside designation, issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order valued at $4,644.32 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024 by the Defense Logistics Agency (DLA), a defense agency. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $8,212.23 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,161.08 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,304.28 fixed-price delivery order is for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has a period of performance through February 10, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3ES
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $10,158.96 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 30, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 8/28/24, 11:17 AM